Fundraising Fox
Corvent Medical
Fargo, US · Founded 2020 · Delaware corporation · 42 employees on LinkedIn · 1 known investors
Find your way into Corvent Medical
Sign up to see every warm intro you have to Corvent Medical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Corvent Medical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
CorVent Medical develops medical ventilators, including the RESPOND ventilator, that provide ICU-standard respiratory support for acute and post-acute patients. Its systems are designed for hospitals, clinics, and private care providers for both daily use and overflow or emergency situations.
Founders & leadership
MT
Murphy TravisChief Financial OfficerExecutive Officer at CorVent Medical, which develops medical ventilators for ICU-level respiratory support. Travis brings over three decades of financial leadership experience across startups and growing healthcare technology companies, including work in finance, accounting, strategic planning, and fundraising from private equity, public markets, and debt sources.
RS
Richard S. WalshCEO, CorVent MedicalRichard S. Walsh is CEO and Board Member at CorVent Medical. With over 30 years in medical device leadership, he has held cross-functional roles in sales, marketing, regulatory affairs, and investor relations at multiple companies, and previously participated in liquidity events involving billions in enterprise value.
RF
Rob FaulknerNamed on SEC filing
LG
Lukas GeuntherNamed on SEC filing
Board
MG
MT
Mark TibblesBoard director
JO
John O'ConnorBoard director
RS
Randy SchneiderBoard director
JB
John BallantyneBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$13.7M disclosed across 3 rounds · 2020–2024
▶$3.8MraisedJun 2025 · 4 investors · Other Health CareRule 506(b)
▶$3.8MraisedJun 2025 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Richard S. WalshExecutive Officer, Director
- Jeremy NelsonExecutive Officer
- John O'ConnorDirector
- Mark GelfandDirector
- John A. BallantyneDirector
- Travis MurphyExecutive Officer
- John O'MahonyExecutive Officer
- Randy SchneiderDirector
- Offering amount
- $6.5M
- Amount sold
- $3.8M
- First sale
- Dec 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$5.4MraisedDec 2024 · 6 investors · Other Health CareRule 506(b)
▶$5.4MraisedDec 2024 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Murphy TravisExecutive Officer
- Jeremy NelsonExecutive Officer
- Mark GelfandDirector
- Mark TibblesDirector
- Richard S. WalshExecutive Officer, Director
- John O'ConnorDirector
- John O'MahonyExecutive Officer
- Randy SchneiderDirector
- John BallantyneDirector
- Offering amount
- $5.4M
- Amount sold
- $5.4M
- First sale
- Dec 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$4.5MraisedMay 2020 · 6 investors · Other Health CareRule 506(b)
▶$4.5MraisedMay 2020 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Mark GelfandExecutive Officer, Director
- Rob FaulknerDirector
- Lukas GeuntherDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- First sale
- Apr 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Corvent Medical went on to found or lead other companies.
Related companies · 3
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
ArriventArriVent BioPharma is a clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing medicines for difficult-to-treat diseases, starting with cancers. Its pipeline centers on its lead candidate firmonertinib (formerly furmonertinib) and novel oncology therapeutics such as next-generation antibody drug conjugates.
SolventumSolventum is a healthcare company that develops medical solutions, including wound care technology such as Acera Surgical's Restrata product, for surgeons, patients, and the broader healthcare sector.
Companies working in the same space as Corvent Medical.
Frequently asked questions
- What does Corvent Medical do?
- CorVent Medical develops medical ventilators, including the RESPOND ventilator, that provide ICU-standard respiratory support for acute and post-acute patients. Its systems are designed for hospitals, clinics, and private care providers for both daily use and overflow or emergency situations.
- Who are Corvent Medical's investors?
- Corvent Medical's investors include Sofinnova Partners.
- How much funding has Corvent Medical raised?
- Corvent Medical has disclosed $13.7M raised across 3 rounds.
- Where is Corvent Medical headquartered?
- Corvent Medical is headquartered in Fargo, US.